![Takaaki Ishii](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Takaaki Ishii
Inversor de Capital Privado en Taiho Ventures LLC .
Perfil
Takaaki Ishii, a molecular biologist by training, joined Taiho Ventures in 2019.
He has acquired over 11 years of oncology expertise in early stage clinical development, product portfolio strategies as well as scientific evaluations for in-house and potential partnering programs in a wide range of cancer types.
His representative contribution to Taiho Pharmaceutical includes in-licensing AB928 (A2aR/A2bR Dual Antagonist) from Arcus Biosciences as well as both medical and Medical Science Liaison activities for nab-paclitaxel (ABRAXANE®) and pembrolizumab (KEYTRUDA®) in Japan.
Cargos activos de Takaaki Ishii
Empresas | Cargo | Inicio |
---|---|---|
Taiho Ventures LLC
![]() Taiho Ventures LLC Investment ManagersFinance Taiho Ventures LLC (Taiho Ventures) is a venture and private equity subsidiary of Taiho Pharmaceutical Co Ltd founded in 2016. The firm is headquartered in Menlo Park, California. | Inversor de Capital Privado | 01/01/2019 |
Formación de Takaaki Ishii.
Tokyo Institute of Technology | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Taiho Ventures LLC
![]() Taiho Ventures LLC Investment ManagersFinance Taiho Ventures LLC (Taiho Ventures) is a venture and private equity subsidiary of Taiho Pharmaceutical Co Ltd founded in 2016. The firm is headquartered in Menlo Park, California. | Finance |
- Bolsa de valores
- Insiders
- Takaaki Ishii